Nesvacumab
Sign in to saveNesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. , the drug was in Phase II clinical trials for the treatment of diabetic macular edema.
~1 min read
Article
1 sectionsContents
- References
Nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. , the drug was in Phase II clinical trials for the treatment of diabetic macular edema.
This drug is being developed by Regeneron Pharmaceuticals.
Connections
fusion protein
Entity
phase of clinical research
Entity
human
Entity
bone
Entity
circulatory system
Entity
digital object identifier
Entity
chemical formula
Entity
insulin
Entity
neurology
Entity
testosterone
Entity
molar mass
Entity
Q180686
Entity
antigen
Entity
CAS Registry Number
Entity
erythropoietin
Gene
neoplasm
Entity
Anatomical Therapeutic Chemical Classification System
Entity
dexamethasone
Entity
amitriptyline
Entity
human musculoskeletal system
Entity